Laddar populära aktier...
Pharma Equity Group (“PEG” or “the Company”) continues to make clinical progress, as demonstrated by...
Prolight’s report for Q1’24 did not reveal any particular surprises.
NoHo Partners will host a Capital Markets Day on Wednesday, 22 May.
Ascelia’s Q1 result was minor compared to the recent SPARKLE success.
Nettoomsättningen för det första kvartalet uppgick till 10,9 MEURO (9,4), vilket motsvarade en öknin...
Redeye initiates coverage of Navigo Invest, a holding company of strategic acquirer platforms.
Redeye revises our forecast and valuation following TH1NG’s Q1 2024 report.
Hög försäljningstillväxt EQL Pharma ökade de återkommande intäkterna med 46,0 procent, vilket var i ...
22% organic sales growth y-o-y Lower than expected gross margin Price increases should help gross ma...
Arctic Blue Beverages AB (”Arctic Blue Beverages” eller ”Bolaget”) har presenterat Bolagets Q1-rappo...
Record start to '24, driven by Capital Markets and PI We increase adj.
Redeye provides a reseach update following the Q1 2024 report from Fragbite Group.
Redeye returns with a research update following Xbrane’s Q1 report.
Rudd delivers SEK 60m EBIT in its first full quarter (ABGSCe 68m) EBIT down by 9-7% for '24e-'26e, l...
We make minor cuts to our estimates after Ferronordic's Q1 results.